This inventor holds 1 USPTO granted patent. Top assignees: National Institute for Korean Medicine Development, Novmetapharma Co., Ltd.. Active years: 2022.
Company Filing History:
1 out of 2 
1 out of 15 Years Active: 2022
Title: Hwa Dong Lee: Innovator in Antithrombotic Composition
Introduction
Hwa Dong Lee is a notable inventor based in Gyeongsangbuk-do, South Korea. He has made significant contributions to the field of herbal medicine, particularly in the development of antithrombotic compositions. His work focuses on creating effective solutions for preventing and treating thrombosis.
Latest Patents
Hwa Dong Lee holds 1 patent for an antithrombotic composition. This invention includes active ingredients derived from Sieb. et Zucc. and is designed to inhibit platelet aggregation and delay thrombosis. The composition is particularly effective and can be utilized as a health food or herbal medicine aimed at preventing thrombotic conditions.
Career Highlights
Throughout his career, Hwa Dong Lee has worked with esteemed organizations such as the National Institute for Korean Medicine Development and Novmetapharma Co., Ltd. His experience in these institutions has allowed him to advance his research and contribute to the field of medicinal innovations.
Collaborations
Hwa Dong Lee has collaborated with notable colleagues, including Hyo Jung Kim and Sun Gun Kim. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Hwa Dong Lee's contributions to the field of antithrombotic compositions highlight his innovative spirit and dedication to improving health outcomes. His work continues to influence the development of effective herbal medicine solutions.